These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 3494784)

  • 21. The role of an autoantigen, histidyl-tRNA synthetase, in the induction and maintenance of autoimmunity.
    Miller FW; Waite KA; Biswas T; Plotz PH
    Proc Natl Acad Sci U S A; 1990 Dec; 87(24):9933-7. PubMed ID: 1702223
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Patients with non-Jo-1 anti-RNA-synthetase autoantibodies have worse survival than Jo-1 positive patients.
    Hervier B; Devilliers H; Benveniste O
    Ann Rheum Dis; 2013 Jul; 72(7):e18. PubMed ID: 23644669
    [No Abstract]   [Full Text] [Related]  

  • 23. [How can we diagnose and better understand inflammatory myopathies? The usefulness of auto-antibodies].
    Sibilia J; Chatelus E; Meyer A; Gottenberg JE; Sordet C; Goetz J
    Presse Med; 2010 Oct; 39(10):1010-25. PubMed ID: 20655695
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Immunologic tests: Anti-Jo-l antibody (anti-histidyl transfer RNA synthetase antibody)].
    Katsuki Y; Hirakata M
    Nihon Rinsho; 2005 Jul; 63 Suppl 7():505-7. PubMed ID: 16111315
    [No Abstract]   [Full Text] [Related]  

  • 25. Clinical heterogeneity and prognostic features of South Australian patients with anti-synthetase autoantibodies.
    Dugar M; Cox S; Limaye V; Blumbergs P; Roberts-Thomson PJ
    Intern Med J; 2011 Sep; 41(9):674-9. PubMed ID: 20059602
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Polymyositis.
    Targoff IN
    Immunol Ser; 1991; 54():201-46. PubMed ID: 1954276
    [No Abstract]   [Full Text] [Related]  

  • 27. The association of anti-Ro52 autoantibodies with myositis and scleroderma autoantibodies.
    Frank MB; McCubbin V; Trieu E; Wu Y; Isenberg DA; Targoff IN
    J Autoimmun; 1999 Mar; 12(2):137-42. PubMed ID: 10047434
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibodies to La, Jo-1, nRNP and Sm detected by multi-track immunoblotting using a novel filter holder: a comparative study with counterimmunoelectrophoresis and immunodiffusion using sera from patients with systemic lupus erythematosus and Sjögren's syndrome.
    Williams DG; Stocks MR; Charles PJ; Maini RN
    J Immunol Methods; 1986 Jul; 91(1):65-73. PubMed ID: 3088125
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Histidyl-tRNA synthetase, the myositis Jo-1 antigen, is cytoplasmic and unassociated with the cytoskeletal framework.
    Dang CV; LaDuca FM; Bell WR
    Exp Cell Res; 1986 May; 164(1):261-6. PubMed ID: 3956597
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical and immunogenetic features of patients with autoantibodies to asparaginyl-transfer RNA synthetase.
    Hirakata M; Suwa A; Takada T; Sato S; Nagai S; Genth E; Song YW; Mimori T; Targoff IN
    Arthritis Rheum; 2007 Apr; 56(4):1295-303. PubMed ID: 17393393
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical manifestations in patients with antibody to PL-12 antigen (alanyl-tRNA synthetase).
    Targoff IN; Arnett FC
    Am J Med; 1990 Mar; 88(3):241-51. PubMed ID: 2178410
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The precipitating antibody to an acidic nuclear protein antigen, the Jo-1, in connective tissue diseases. A marker for a subset of polymyositis with interstitial pulmonary fibrosis.
    Yoshida S; Akizuki M; Mimori T; Yamagata H; Inada S; Homma M
    Arthritis Rheum; 1983 May; 26(5):604-11. PubMed ID: 6405755
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cellular localization of the target structures recognized by the anti-Jo-1 antibody: immunofluorescence studies on cultured human myoblasts.
    Shi MH; Tsui FW; Rubin LA
    J Rheumatol; 1991 Feb; 18(2):252-8. PubMed ID: 2023220
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-Ro52 antibodies frequently co-occur with anti-Jo-1 antibodies in sera from patients with idiopathic inflammatory myopathy.
    Rutjes SA; Vree Egberts WT; Jongen P; Van Den Hoogen F; Pruijn GJ; Van Venrooij WJ
    Clin Exp Immunol; 1997 Jul; 109(1):32-40. PubMed ID: 9218821
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Secreted histidyl-tRNA synthetase splice variants elaborate major epitopes for autoantibodies in inflammatory myositis.
    Zhou JJ; Wang F; Xu Z; Lo WS; Lau CF; Chiang KP; Nangle LA; Ashlock MA; Mendlein JD; Yang XL; Zhang M; Schimmel P
    J Biol Chem; 2014 Jul; 289(28):19269-75. PubMed ID: 24898250
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Destructive arthropathy associated with dermatomyositis sine myositis positive for anti-Jo-1 and anti-cyclic citrullinated peptide antibodies.
    Nagashima T; Sato H; Minota S
    J Rheumatol; 2009 Sep; 36(9):2133-4. PubMed ID: 19738232
    [No Abstract]   [Full Text] [Related]  

  • 37. Sera from anti-Jo-1-positive patients with polymyositis and interstitial lung disease induce expression of intercellular adhesion molecule 1 in human lung endothelial cells.
    Barbasso Helmers S; Englund P; Engström M; Ahlin E; Fathi M; Janciauskiene S; Heimbürger M; Rönnelid J; Lundberg IE
    Arthritis Rheum; 2009 Aug; 60(8):2524-30. PubMed ID: 19644880
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A woman with anti-histidyl-aminoacyl-tRNA synthetase (Jo-1 antibodies), myositis, hyperglycemia, interstitial lung disease, and morbilliform rashes.
    Tsai CY; Tsai YY; Kuo HL; Chou CT
    Rheumatol Int; 2005 Mar; 25(2):156-7. PubMed ID: 14770267
    [No Abstract]   [Full Text] [Related]  

  • 39. Humoral immunity in polymyositis/dermatomyositis.
    Targoff IN
    J Invest Dermatol; 1993 Jan; 100(1):116S-123S. PubMed ID: 8423380
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Update on myositis-specific and myositis-associated autoantibodies.
    Targoff IN
    Curr Opin Rheumatol; 2000 Nov; 12(6):475-81. PubMed ID: 11092195
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.